Investors in EUDA Health Holdings (NASDAQ:EUDA) from a year ago are still down 72%, even after 42% gain this past week

Over the last month the EUDA Health Holdings Limited (NASDAQ:EUDA) has been much stronger than before, rebounding by 84%. But that doesn't change the fact that the returns over the last year have been stomach churning. Specifically, the stock price nose-dived 72% in that time. So it's not that amazing to see a bit of a bounce. The real question is whether the company can turn around its fortunes.

The recent uptick of 42% could be a positive sign of things to come, so let's take a look at historical fundamentals.

View our latest analysis for EUDA Health Holdings

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

During the last year EUDA Health Holdings saw its earnings per share drop below zero. While this may prove temporary, we'd consider it a negative, so it doesn't surprise us that the stock price is down. However, there may be an opportunity for investors if the company can recover.

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. It might be well worthwhile taking a look at our free report on EUDA Health Holdings' earnings, revenue and cash flow.

A Different Perspective

EUDA Health Holdings shareholders are down 72% for the year, even worse than the market loss of 7.3%. That's disappointing, but it's worth keeping in mind that the market-wide selling wouldn't have helped. It's great to see a nice little 73% rebound in the last three months. Let's just hope this isn't the widely-feared 'dead cat bounce' (which would indicate further declines to come). I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - EUDA Health Holdings has 6 warning signs (and 4 which don't sit too well with us) we think you should know about.

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.